132
Views
32
CrossRef citations to date
0
Altmetric
Genetic and Molecular Basis of Cardiac Arrhythmias

A missense mutation in CASQ2 is associated with autosomal recessive catecholamine‐induced polymorphic ventricular tachycardia in Bedouin families from Israel

, &
Pages 87-91 | Published online: 08 Jul 2009

References

  • Reid DS, Tynan M, Braidwood L, Fitzgerald GR. Bidirec-tional tachycardia in a child: A study using His bundle electrography. Br Heart J 1975;37:33911.
  • Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children: a 7 year follow up of 21 patients. Circulation 1995; 91:1512–9.
  • Viskin S, Belhassen B. Polymorphic ventricular tachyarrhyth-mias in the absence of organic heart disease: Classification, differential diagnosis, and implication for therapy. Prog Cardiovasc Dis 1998;41:17–34.
  • Shaw T. Recurrent ventricular fibrillation associated with normal QT intervals. QJM 1981;200:451–62.
  • Eisenberg SJ, Scheinman MM, Dullet NK, Finkbeiner WE, Griffin JC, Eldar M, et al. Sudden cardiac death and polymorphous ventricular tachycardia in patients with nor-mal QT intervals and normal systolic cardiac function. Am J Cardiol 1995;75:687–92.
  • Swan H, Piippo K, Viitasalo M, Heikkila P, Paavonen T, Kainulainen K, et al. Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventri-cular tachycardia in structurally normal hearts. J Am Coll Cardiol 1999;34:2035–42.
  • Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ven-tricular tachycardia. Circulation 2001;103:196–200.
  • Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485–90.
  • Stokes DL, Wagenknecht T. Calcium transport across the sarcoplasmic reticulum: structure and function of Ca2+-ATPase and the ryanodine receptor. Eur J Biochem 2000; 267:5274–9.
  • Lahat H, Eldar M, Levy-Nissenbaum E, Bahan T, Friedman E, Khoury A, et al. Autosomal recessive catecholamine- or exercise-induced polymorphic ± ventricular tachycardia: clin-ical features and assignment of the disease gene to chromo-some 1p13-21. Circulation 2001;103: 2822–7.
  • Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A mis sense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001;69: 1378–84.
  • Yano K, Zarain-Herzberg A. Sarcoplasmic reticulum calse-questrins: structural and functional properties. Mol Cell Biochem 1994;135:61–70.
  • Wang S, Trumble WR, Liao H, Wesson CR, Dunker AK, Kang CH. Crystal structure of calsequastrin from rabbit skeletal muscle sarcoplasmic reticulum. Nat Struct Biol 1998; 5:476–83.
  • Zhang L, Kelley J, Schmeisser G, Kobayashi YM, Jones LR. Complex formation between junctin, triadin, calsequestrin, and the ryanodine receptor. Proteins of the cardiac junctional sarcoplasmic reticulum membrane. J Biol Chem 1997; 272: 23389–97.
  • MacLennan DH, Reithmeier RA. Ion tamers. Nat Struct Biol 1998;5:409–11.
  • Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985;17:291–306.
  • Marban E, O'Rourke B. Calcium channels: structure, func-tion, and regulation, in Cardiac Electrophysiology. In: DP Zipes, J Jaliffe, eds. From cell to bedside. Philadelphia: WB Saunders Comp; 1995:11–21.
  • Rubart M, Zipes DP. Genesis of cardiac arrhythmias: electrophysiological considerations, in heart disease. In: E. Braunwald et al, eds. Heart disease: A textbook of cardio-vascular medicine. Philadelphia: WB Saunders Comp; 2001: 680–4.
  • Priori SG, Corr PB. Mechanisms underlying early and delayed after depolarizations induced by catecholamines. Am J Physiol 1990;258:H1796–805.
  • Postma AV, Isabelle D, Theo MH, Lupoglazoff JM, Da Costa A, Sebillion P, et al. Absence of Calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachy-cardia. Circ Res 2002;91:e21–6.
  • Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69–74.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.